Detalhe da pesquisa
1.
COVID-19 and financial toxicity in patients with renal cell carcinoma.
World J Urol
; 39(7): 2559-2565, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33090258
2.
Distress in patients with renal cell carcinoma: a curious gap in knowledge.
BJU Int
; 123(2): 208-209, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30253048
3.
Everolimus in metastatic renal cell carcinoma after failure of initial vascular endothelial growth factor receptor-tyrosine kinase inhibitor (VEGFr-TKI) therapy: results of an interim analysis of a non-interventional study.
Onkologie
; 36(3): 95-100, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23485996
4.
Liver resection for metastatic disease prolongs survival in renal cell carcinoma: 12-year results from a retrospective comparative analysis.
World J Urol
; 28(4): 543-7, 2010 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-20440505
5.
Sources of Frustration Among Patients Diagnosed With Renal Cell Carcinoma.
Front Oncol
; 9: 11, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30723705
6.
Randomized Open-Label Phase II Trial of Apitolisib (GDC-0980), a Novel Inhibitor of the PI3K/Mammalian Target of Rapamycin Pathway, Versus Everolimus in Patients With Metastatic Renal Cell Carcinoma.
J Clin Oncol
; 34(14): 1660-8, 2016 05 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-26951309